Targeting autophagy in disease: established and new strategies

M Kocak, S Ezazi Erdi, G Jorba, I Maestro, J Farrés… - Autophagy, 2022‏ - Taylor & Francis
Macroautophagy/autophagy is an evolutionarily conserved pathway responsible for clearing
cytosolic aggregated proteins, damaged organelles or invading microorganisms …

Research progress of mTOR inhibitors

Y Chen, X Zhou - European journal of medicinal chemistry, 2020‏ - Elsevier
Mammalian target of rapamycin (mTOR) is a highly conserved Serine/Threonine (Ser/Thr)
protein kinase, which belongs to phosphatidylinositol-3-kinase-related kinase (PIKK) protein …

Glucose-driven TOR–FIE–PRC2 signalling controls plant development

R Ye, M Wang, H Du, S Chhajed, J Koh, K Liu, J Shin… - Nature, 2022‏ - nature.com
Nutrients and energy have emerged as central modulators of developmental programmes in
plants and animals,–. The evolutionarily conserved target of rapamycin (TOR) kinase is a …

Targeting PI3K/AKT/mTOR pathway in non small cell lung cancer

C Fumarola, MA Bonelli, PG Petronini… - Biochemical …, 2014‏ - Elsevier
Abstract While PI3K/AKT/mTOR pathway is altered in a variety of cancers including non
small cell lung cancer, abnormalities in this pathway are more common in squamous cell …

mTOR inhibitors in cancer therapy

J **e, X Wang, CG Proud - F1000Research, 2016‏ - pmc.ncbi.nlm.nih.gov
The mammalian target of rapamycin, mTOR, plays key roles in cell growth and proliferation,
acting at the catalytic subunit of two protein kinase complexes: mTOR complexes 1 and 2 …

Regulation of autophagy by mTOR-dependent and mTOR-independent pathways: autophagy dysfunction in neurodegenerative diseases and therapeutic application …

S Sarkar - Biochemical Society Transactions, 2013‏ - portlandpress.com
Autophagy is an intracellular degradation pathway essential for cellular and energy
homoeostasis. It functions in the clearance of misfolded proteins and damaged organelles …

[HTML][HTML] Progress towards a clinically-successful ATR inhibitor for cancer therapy

FM Barnieh, PM Loadman, RA Falconer - Current research in …, 2021‏ - Elsevier
The DNA damage response (DDR) is now known to play an important role in both cancer
development and its treatment. Targeting proteins such as ATR (Ataxia telangiectasia …

Autophagy in health and disease: From molecular mechanisms to therapeutic target

G Lu, Y Wang, Y Shi, Z Zhang, C Huang, W He… - MedComm, 2022‏ - Wiley Online Library
Macroautophagy/autophagy is an evolutionally conserved catabolic process in which
cytosolic contents, such as aggregated proteins, dysfunctional organelle, or invading …

Roles of mTOR complexes in the kidney: implications for renal disease and transplantation

D Fantus, NM Rogers, F Grahammer… - Nature Reviews …, 2016‏ - nature.com
The mTOR pathway has a central role in the regulation of cell metabolism, growth and
proliferation. Studies involving selective gene targeting of mTOR complexes (mTORC1 and …

Targeting ATM and ATR for cancer therapeutics: Inhibitors in clinic

B Priya, S Ravi, S Kirubakaran - Drug Discovery Today, 2023‏ - Elsevier
Highlights•Genome sequencing has made personalized therapy the preferred cancer
therapeutic approach.•In the past decade, the relevance of targeting DDR kinases for cancer …